X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17545) 17545
Book Chapter (108) 108
Magazine Article (63) 63
Book / eBook (30) 30
Newsletter (14) 14
Conference Proceeding (7) 7
Dissertation (7) 7
Publication (6) 6
Reference (4) 4
Government Document (3) 3
Newspaper Article (2) 2
Web Resource (2) 2
Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14671) 14671
immunosuppression (11559) 11559
male (7915) 7915
female (7491) 7491
transplantation (5930) 5930
adult (5700) 5700
middle aged (5520) 5520
immunosuppression - adverse effects (4360) 4360
surgery (3728) 3728
immunology (3091) 3091
immunosuppressive agents - therapeutic use (3001) 3001
animals (2938) 2938
immunosuppressive agents - adverse effects (2823) 2823
kidney transplantation (2709) 2709
aged (2533) 2533
risk factors (2412) 2412
immunotherapy (2360) 2360
adolescent (2173) 2173
treatment outcome (2107) 2107
child (1918) 1918
recipients (1844) 1844
retrospective studies (1805) 1805
kidney transplantation - adverse effects (1782) 1782
immunosuppression - methods (1682) 1682
time factors (1577) 1577
therapy (1503) 1503
cyclosporine (1417) 1417
graft rejection - prevention & control (1383) 1383
health aspects (1380) 1380
graft rejection (1320) 1320
follow-up studies (1308) 1308
tacrolimus (1282) 1282
kidneys (1248) 1248
cancer (1207) 1207
mice (1184) 1184
liver transplantation (1137) 1137
immunosuppressive agents - administration & dosage (1113) 1113
transplants & implants (1099) 1099
infection (1081) 1081
child, preschool (1061) 1061
oncology (1060) 1060
analysis (1051) 1051
disease (1035) 1035
transplantation, homologous (1028) 1028
graft survival (1026) 1026
immunosuppressive agents (989) 989
organ transplant recipients (940) 940
urology & nephrology (938) 938
risk (927) 927
incidence (905) 905
hematology (893) 893
liver (889) 889
patients (879) 879
care and treatment (862) 862
drug therapy, combination (860) 860
gastroenterology & hepatology (860) 860
mycophenolate-mofetil (858) 858
renal-transplantation (852) 852
rejection (850) 850
kidney transplantation - immunology (846) 846
pediatrics (845) 845
liver transplantation - adverse effects (827) 827
young adult (819) 819
prognosis (816) 816
research (803) 803
prospective studies (785) 785
survival (781) 781
graft rejection - immunology (766) 766
medicine, general & internal (754) 754
infectious diseases (750) 750
immunocompromised host (743) 743
infant (740) 740
cyclosporine - therapeutic use (735) 735
infections (731) 731
biopsy (727) 727
lymphocytes (720) 720
kidney-transplantation (718) 718
calcineurin inhibitors (716) 716
children (716) 716
mortality (714) 714
transplantation of organs, tissues, etc (680) 680
medicine & public health (672) 672
risk-factors (655) 655
tacrolimus - therapeutic use (644) 644
pharmacology & pharmacy (642) 642
recurrence (634) 634
cyclosporine - adverse effects (632) 632
inflammation (631) 631
heart transplantation (618) 618
dermatology (616) 616
sirolimus (611) 611
postoperative complications (600) 600
prevention (579) 579
mycophenolic acid - analogs & derivatives (569) 569
survival rate (546) 546
t cells (541) 541
diagnosis (533) 533
tacrolimus - adverse effects (532) 532
immune system (526) 526
medical research (526) 526
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Scarborough - Circulation Desk (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16487) 16487
French (511) 511
German (299) 299
Spanish (200) 200
Italian (59) 59
Japanese (52) 52
Polish (52) 52
Russian (51) 51
Portuguese (30) 30
Chinese (24) 24
Czech (24) 24
Croatian (14) 14
Dutch (13) 13
Hungarian (12) 12
Norwegian (11) 11
Swedish (10) 10
Bulgarian (7) 7
Danish (5) 5
Turkish (5) 5
Hebrew (3) 3
Korean (2) 2
Serbian (2) 2
Arabic (1) 1
Finnish (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 01/2016, Volume 6, Issue 1, pp. 19200 - 19200
Although the heavy metals cadmium (Cd) and lead (Pb) are known environmental health concerns, their long-term impacts on gut ecology and susceptibility to... 
INFLAMMATORY-BOWEL-DISEASE | METALLOTHIONEIN | PROTECTIVE ROLE | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | IN-VIVO | CHRONIC INGESTION | GENE-EXPRESSION | RATS | INDUCTION | METALLOHORMONE CADMIUM | Immunomodulation - drug effects | Dextran Sulfate - adverse effects | Colitis - pathology | Salmonella typhimurium | Intestinal Mucosa - drug effects | Cadmium - adverse effects | Lead - adverse effects | Trinitrobenzenesulfonic Acid - adverse effects | Time Factors | Immune System - immunology | Female | Metals, Heavy - administration & dosage | Disease Models, Animal | Metals, Heavy - adverse effects | Disease Susceptibility | Salmonella Infections - complications | Administration, Oral | Immune System - cytology | Colitis - etiology | Animals | Immune System - drug effects | Salmonella Infections - microbiology | Mice | Lead - administration & dosage | Cadmium - administration & dosage | Intestinal Mucosa - pathology | Salmonella | Cell culture | Cadmium | Drinking water | Inflammatory bowel diseases | Animal models | Digestive system | Sulfonic acid | Heavy metals | Dextran | Inflammatory bowel disease | Immunosuppression | Sodium | Intestine | Sodium sulfate | Rodents | Colon | Sulfate | Colitis | Autoimmune diseases | Digestive tract | Index Medicus | Dextran Sulfate/adverse effects | Disease Models | Trinitrobenzenesulfonic Acid/adverse effects | Metals | Heavy/adverse effects | Toxicology and food chain | Colitis/pathology | Immune System/immunology | Intestinal Mucosa/pathology | Intestinal Mucosa/drug effects | Life Sciences | Toxicology | Immunomodulation/drug effects | Salmonella Infections/microbiology | Animal | Colitis/etiology | Cadmium/administration & dosage
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2016, Volume 65, Issue 5, pp. 1350 - 1361
Transplantation of pancreatic islets is a therapeutic option to preserve or restore -cell function. Our study was aimed at developing a clinically applicable... 
LONG-TERM | DIABETES-MELLITUS | CELLS | MEDIATED INFLAMMATORY REACTION | OMENTAL POUCH SITE | ENDOCRINOLOGY & METABOLISM | GRAFT-SURVIVAL | COLD PRESERVATION | HEPATIC STEATOSIS | TISSUE FACTOR | BLOOD | Tissue Scaffolds - adverse effects | Diabetes Mellitus, Experimental - surgery | Pancreas, Artificial - adverse effects | Biocompatible Materials - chemistry | Rats, Inbred Lew | Macaca fascicularis | Male | Omentum | Recombinant Proteins - adverse effects | Feasibility Studies | Tissue Scaffolds - chemistry | Diabetes Mellitus, Experimental - blood | Islets of Langerhans Transplantation - immunology | Plasma - metabolism | Immunosuppression - adverse effects | Islets of Langerhans Transplantation - adverse effects | Islets of Langerhans - cytology | Islets of Langerhans Transplantation - pathology | Surface Properties | Female | Islets of Langerhans - ultrastructure | Rats, Inbred WF | Tissue Engineering | Recombinant Proteins - metabolism | Hyperglycemia - prevention & control | Microscopy, Electron, Scanning | Recombinant Proteins - chemistry | Biomarkers - blood | Islets of Langerhans Transplantation - methods | Diabetes Mellitus, Experimental - immunology | Animals | Thrombin - chemistry | Transplantation, Isogeneic - adverse effects | Plasma - chemistry | Transplantation, Heterologous - adverse effects | Diabetes Mellitus, Experimental - pathology | Transplantation, Heterotopic - adverse effects | Thrombin - adverse effects | Thrombin - metabolism | Biocompatible Materials - adverse effects | Islet cell transplantation | Usage | Clinical trials | Dosage and administration | Inflammation | Research | Glucose tolerance tests | Insulin | Risk factors | Immunology and Transplantation
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 03/2017, Volume 2017, Issue 10, p. CD011639
Background As part of liver transplantation, immunosuppression (suppressing the host immunity) is given to prevent graft rejections resulting from the immune... 
Liver Transplantation | LIVER TRANSPLANTATION AND RELATED SURGERY (KJJC) (ACCORDING TO NCSP) | Immunosuppressive Agents | Glucocorticoids | Sirolimus | Gastroenterology & hepatology | Liver disorders | Transplantation | Cyclosporine | Mycophenolic Acid | Retreatment | Immunosuppression | Tacrolimus | Maintenance immunosuppression | Bayes Theorem | Transplantation Immunology | Network Meta‐Analysis | Azathioprine | Drug Therapy, Combination | Odds Ratio | Medicine General & Introductory Medical Sciences | Everolimus | TRANSPLANTATION: SOLID ORGAN | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppression - methods | Humans | Immunosuppressive Agents - therapeutic use | Immunosuppression - mortality | Immunosuppression - adverse effects | Everolimus - adverse effects | Adult | Everolimus - therapeutic use | Network Meta-Analysis | Glucocorticoids - adverse effects | Sirolimus - adverse effects | Sirolimus - therapeutic use | Liver Transplantation - mortality | Retreatment - statistics & numerical data | Tacrolimus - adverse effects | Cyclosporine - therapeutic use | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Drug Therapy, Combination - mortality | Mycophenolic Acid - therapeutic use | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Azathioprine - adverse effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2020, Issue 3, p. CD000545
Background The results from controlled clinical trials investigating the efficacy of azathioprine and 6‐mercaptopurine for the treatment of active Crohn's... 
Mesalamine | Immunosuppressive Agents | Glucocorticoids | Gastroenterology & hepatology | Azathioprine or 6‐mercaptopurine therapy | Crohn Disease | Induction Chemotherapy | Prednisone | Withholding Treatment | Antimetabolites | Randomized Controlled Trials as Topic | Crohn's disease: induction of remission | Inflammatory bowel disease | CROHN'S DISEASE ‐ INDUCTION OF REMISSION | Infliximab | Sulfasalazine | Azathioprine | Medicine General & Introductory Medical Sciences | Mercaptopurine | LONG-TERM | CLINICAL-PHARMACOLOGY | Induction Chemotherapy [methods] | Humans | 6-Mercaptopurine [adverse effects; therapeutic use] | RANDOMIZED-TRIAL | EARLY COMBINED IMMUNOSUPPRESSION | Immunosuppressive Agents [adverse effects; therapeutic use] | INFLIXIMAB PLUS AZATHIOPRINE | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | Crohn Disease [drug therapy] | DOUBLE-BLIND TRIAL | TERM-FOLLOW-UP | Azathioprine [adverse effects; therapeutic use] | MYCOPHENOLATE-MOFETIL | Sulfasalazine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Mercaptopurine - adverse effects | Antimetabolites - therapeutic use | Infliximab - therapeutic use | Antimetabolites - adverse effects | Mercaptopurine - therapeutic use | Crohn Disease - drug therapy | Mesalamine - therapeutic use | Adult | Immunosuppressive Agents - adverse effects | Induction Chemotherapy - statistics & numerical data | Azathioprine - adverse effects
Journal Article
by Ju, UH and Liu, FC and Lin, CS and Huang, WY and Lin, TY and Shen, CH and Chou, YC and Lin, CL and Lin, KT and Kao, CH and Chen, CH and Yang, TY
MEDICINE, ISSN 0025-7974, 04/2019, Volume 98, Issue 14, p. e14984
Journal Article
Book Review